| Stock | Signals | Price | Market cap | Avg $ volume | P/E | 63D | 126D | 252D | From 52W high | Vs SMA50 | Vs SMA200 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSCCentury Therapeutics, Inc. Common Stock | -- |
$1.50 | $271.61M | $1.11M | -- | -33.33% | -38.52% | +168.00% | -50.66% | -18.69% | -28.37% |
| DNMXDynamix Corporation III Class A Ordinary Shares | -- |
$10.10 | $271.02M | $659.28K | -- | +0.90% | +1.92% | -- | -0.05% | +0.44% | -- |
| ARLAmerican Realty Investors, Inc. | -- |
$16.77 | $270.87M | $84.78K | 32.4 | +5.60% | +19.27% | +10.18% | -31.38% | +6.61% | +5.18% |
| EYPTEyePoint, Inc. Common Stock | -- |
$3.14 | $270.71M | $11.84M | -- | -76.39% | -78.80% | -76.14% | -83.57% | -41.88% | -73.57% |
| CGCFCartesian Growth Corporation IV Class A Ordinary Shares | -- |
$9.83 | $270.32M | $319.52K | -- | -- | -- | -- | -1.70% | -- | -- |
| KINSKingstone Companies, Inc. | -- |
$18.58 | $268.97M | $1.59M | 7.6 | -7.52% | +0.05% | +24.03% | -11.10% | -3.37% | +7.58% |
| PALIPalisade Bio, Inc. Common Stock | -- |
$1.54 | $268.38M | $5.49M | -- | -21.83% | -33.91% | -16.76% | -46.06% | -15.93% | -18.70% |
| ELVAElectrovaya Inc. Common Shares | -- |
$5.36 | $267.99M | $2.28M | -- | -43.46% | -44.05% | -27.27% | -58.06% | -20.36% | -37.67% |
| PCYOPure Cycle Corporation | -- |
$11.12 | $267.96M | $908.22K | 18.2 | +3.93% | +0.36% | +0.36% | -10.61% | -0.35% | +1.73% |
| TMCITreace Medical Concepts, Inc. Common Stock | -- |
$4.12 | $267.94M | $991.19K | -- | -4.19% | +120.32% | -33.55% | -41.81% | -8.03% | +30.95% |
| LCNBLCNB Corporation | -- |
$18.79 | $267.85M | $544.97K | 11.0 | -1.83% | +13.50% | +25.85% | -11.87% | -2.00% | +6.68% |
| XTERKarman Line Acquisition Corp. Class A Ordinary Shares | -- |
$9.78 | $267.16M | $553.64K | -- | -- | -- | -- | -1.21% | -- | -- |
| CATXPerspective Therapeutics, Inc. | -- |
$2.34 | $267.11M | $5.98M | -- | -21.74% | -45.07% | -51.65% | -62.01% | -19.04% | -34.92% |
| FXNCFIRST NATL CORP STRASBURG VA | -- |
$29.42 | $266.03M | $732.18K | 12.3 | -0.30% | +3.05% | +31.52% | -11.49% | -4.04% | +3.06% |
| BKKTBakkt, Inc. | -- |
$5.90 | $265.91M | $10.61M | -- | -18.62% | -38.28% | -86.90% | -87.49% | -23.98% | -37.32% |
| ABEOAbeona Therapeutics Inc. Common Stock | -- |
$4.65 | $265.91M | $7.56M | -- | -33.57% | -13.57% | -13.08% | -39.22% | -18.73% | -15.96% |
| ALTIAlTi Global, Inc. Class A Common Stock | -- |
$2.31 | $265.81M | $543.22K | -- | -33.24% | -37.40% | -38.56% | -57.58% | -32.50% | -37.83% |
| CATLCatalyst Acquisition Corp. Class A Ordinary Share | -- |
$9.77 | $265.45M | $383.04K | -- | -- | -- | -- | -3.46% | -- | -- |
| MOVECorvex, Inc. Common Stock | -- |
$8.41 | $265.35M | $1.96M | -- | -40.10% | -47.07% | +61.20% | -68.53% | -24.21% | -34.76% |
| PRLDPrelude Therapeutics Incorporated | -- |
$3.32 | $264.95M | $2.05M | -- | -20.95% | -25.06% | +155.38% | -51.39% | -31.40% | -15.94% |